MilWealth Group LLC Acquires Shares of 717 SPDR S&P Biotech ETF (NYSEARCA:XBI)

MilWealth Group LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 717 shares of the exchange traded fund’s stock, valued at approximately $65,000.

A number of other hedge funds also recently modified their holdings of XBI. FMR LLC lifted its position in SPDR S&P Biotech ETF by 13.6% during the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock worth $686,000 after acquiring an additional 830 shares during the last quarter. Ameritas Advisory Services LLC lifted its holdings in SPDR S&P Biotech ETF by 11.9% during the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after purchasing an additional 1,137 shares during the last quarter. Beaton Management Co. Inc. bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $212,000. Robinson Value Management Ltd. grew its holdings in SPDR S&P Biotech ETF by 1.2% in the 3rd quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock valued at $1,329,000 after buying an additional 155 shares in the last quarter. Finally, Hollow Brook Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 4.9% during the 3rd quarter. Hollow Brook Wealth Management LLC now owns 21,669 shares of the exchange traded fund’s stock worth $2,141,000 after buying an additional 1,003 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $92.67 on Monday. The firm has a 50-day moving average of $93.24 and a 200-day moving average of $96.67. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The stock has a market cap of $7.06 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.